(NYSE: AVNT) Avient's forecast annual revenue growth rate of 2.51% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Avient's revenue in 2025 is $3,238,000,000.On average, 5 Wall Street analysts forecast AVNT's revenue for 2025 to be $299,042,884,936, with the lowest AVNT revenue forecast at $295,919,513,966, and the highest AVNT revenue forecast at $302,570,555,926. On average, 5 Wall Street analysts forecast AVNT's revenue for 2026 to be $311,637,512,472, with the lowest AVNT revenue forecast at $309,655,188,377, and the highest AVNT revenue forecast at $316,492,682,486.
In 2027, AVNT is forecast to generate $323,701,158,706 in revenue, with the lowest revenue forecast at $318,625,394,839 and the highest revenue forecast at $326,659,313,118.